Schroders Capital Growth Innovation trust (INOV) has embarked on share repurchase programme, set to run until the end of next year.
According to an RNS announcement the trust - formerly known as the Woodford Patient Capital trust - has hired Winterflood Investment Trusts to manage the "irrevocable" programme to buy back ordinary shares, which will begin today until 31 December 2024. 'Akin to raising the Titanic': Painful tenure for Schroder UK Public Private sparks doubts over its future INOV has also received court approval to cancel its share premium account and said it has "sufficient distributable reserves" to undertake the share repurchase programme. According to its policy, the trust will have general buy...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
